Decrease of 1-methyl-1,2,3,4-tetrahydroisoquinoline synthesizing enzyme activity in the brain areas of aged rat

Brain Research

Volumn 955, Issue 1-2, 2002, Pages 161-163

  Absi, Elhadi ^a   Parrado, Juan ^a   Ayala, Antonio ^a   Machado, Alberto ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

1 Methyl tetrahydroisoquinoline; 1 Methyl tetrahydroisoquinoline synthesizing enzyme; Age; Striatum; Substantia nigra

Indexed keywords

1 METHYL 1,2,3,4 TETRAHYDROISOQUINOLINE; BRAIN MONOAMINE; MONOAMINE DERIVATIVE; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

AGING; ANIMALS; BRAIN; DOWN-REGULATION; ENZYME ACTIVATION; ISOQUINOLINES; MITOCHONDRIA; RATS; RATS, WISTAR; TETRAHYDROISOQUINOLINES;

EID: 0037111299     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03428-5     Document Type: Article

References (19)

1. Ayala A., Parrado J., Cano J., Machado A. Reduction of 1-methyl 1,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat. Brain Res. 638:1994;332-336.
2. Collins M.A., Neafsey E.J. Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism? Neurosci Lett. 55:1985;179-184.
3. Davis V.E., Cashaw J.L., McMurtrey K.D., Ruchirawat S., Nimit Y. Beta-Carbolines and Tetrahydroisoquinolines. 1982;Alan R. Liss, New York.
4. Kawai H., Makino Y., Hirobe M., Ohta S. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce Parkinsonism. J. Neurochem. 70:1988;745-751.
5. Kohno M., Ohta S., Hirobe M. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain. Biochem. Biophys. Res. Commun. 140:1986;448-454.
6. Kotake Y., Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Benzyl-tetrahydroisoquinoline as a Parkinsonism inducing agent: a novel endogenous amine in mouse and parkinsonian CSF. J. Neurochem. 65:1995;2633-2638.
7. Makino Y., Ohta S., Tachikawa O., Hirobe M. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson's disease. Life Sci. 43:1988;373-378.
8. Matsubara K., Gonda T., Sawada H., Uezono T., Kobayashi S., Kawamura T., Ohtaki K., Kimura K., Akaide A. Endogenously occurring beta-carboline induces parkinsonism in nonprimate animal: a possible causative protoxin in idiopatic Parkinson's disease. J. Neurochem. 70:1998;727-735.
9. Melchior C., Collins M.A. The route and significance of endogenous synthesis of alkaloids in animals. CRC Crit. Rev. Toxicol. 9:1982;313-356.
10. Nagatsu T., Yoshida M. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci. Lett. 87:1988;178-182.
11. Niwa T., Takeda N., Kaneda N., Hashizume Y., Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroisoquinoline in parkinsonian and normal human brains. Biochem. Biophys. Res. Commun. 144:1987;1084-1089.
12. Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed. Res. 8:1987;453-456.
13. +. J. Neurochem. 75:2000;65-71.
14. Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Methyl-1-2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behaviour abnormalities. J. Neurochem. 57:1991;1940-1943.
15. Suzuki K., Mizuno Y., Yamauchi Y., Nagatsu T., Mitsuo Y. Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1-2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain. J. Neurol. Sci. 109:1992;219-223.
16. Yamakawa T., Kotoake Y., Fujitani M., Shintani H., Makino Y., Ohta S. Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and a endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain. Neurosci. Lett. 276:1999;68-70.
17. Yamakawa T., Ohta S. Isolation of 1-methyl-1,2,3,4,-tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme. Biochim. Biophys. Res. Commun. 236:1997;676-681.
18. Yamakawa Y., Ohta S. Biosynthesis of a parkinsonism-preventing substance 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitocondrial fraction. Neurosci. Lett. 259:1999;157-160.
19. Yoshida M., Ogawa M., Suzuki K., Nagatsu T. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues. Adv. Neurol. 60:1993;207-211.